BC Cancer - Victoria

2410 Lee Avenue
Victoria, BC, V8R 6V5

Clinical Trial Unit Manager
Philip Pollock
250-519-5597
philip.pollock@bccancer.bc.ca

Hematology

HDC.1/S1826: A Phase III Randomized Study of Nivolumab (Opdivo) or Brentuximab Vedotin (Adcetris) plus AVD in Patients (age >/= 12 Years) with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma

Cancer Type
Hematology
Phase III
Recruiting Dates
BC Cancer - Victoria
Open Recruiting Date
View on ClinicalTrials.gov
Back to top